effect of vitamin D in treatment of men with sexual dysfunction

The effect of vitamin D in treatment of men with sexual dysfunction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201612252342N5

Enrollment

Registered

2017-02-18

Start date

2015-06-26

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Impotence of organic origin

Interventions

Intervention 1: Control group: sildenafil 50mg taken 30-60 minutes before sexual intercourse. Intervention 2: Injection of vitamin D3 300000 IU intramuscularly at baseline then monthly for 3 months Pe

Treatment - Drugs

Control group: sildenafil 50mg taken 30-60 minutes before sexual intercourse

Injection of vitamin D3 300000 IU intramuscularly at baseline then monthly for 3 months Pearl of vitamin D3 50000 IU orally every week for patients with deficiency of vitamin D3

Eligibility

Sex/Gender

Male

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Men with erectile dysfunction diagnosis by urologist Exclusion criteria: Age60, underline disease include: depression, anxiety, drug abuse, heart failure, pectoral angina, hypertension, stroke, dementia, seizure, Parkinson, Cushing syndrome, drugs induced sexual dysfunction: SSRIs, anti-androgens, opioids, alcohol, cimetidine, spironolactone, thiazide, ketoconazole, beta-blockers, methyldopa, clonidine, metoclopramide, phenothiazine's and TCA.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum levels of testosterone. Timepoint: at baseline and monthly over 3 months. Method of measurement: laboratory blood tests.;Sexual function based on IIEF-5 questionnaires. Timepoint: at baseline and monthly over 3 months. Method of measurement: questionnaires.;Sexual function based on IIEF-15 questionnaires. Timepoint: at baseline and monthly over 3 months. Method of measurement: questionnaires.	—

Measure

Time frame

Serum levels of testosterone. Timepoint: at baseline and monthly over 3 months. Method of measurement: laboratory blood tests.;Sexual function based on IIEF-5 questionnaires. Timepoint: at baseline and monthly over 3 months. Method of measurement: questionnaires.;Sexual function based on IIEF-15 questionnaires. Timepoint: at baseline and monthly over 3 months. Method of measurement: questionnaires.

—

Secondary

Measure	Time frame
Serum level of FSH. Timepoint: at baseline and monthly over 3 months. Method of measurement: blood tests.;Serum level of LH. Timepoint: at baseline and monthly over 3 months. Method of measurement: blood tests.;Serum level of prolactin. Timepoint: at baseline and monthly over 3 months. Method of measurement: blood tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShervin Amirkhanloo

Mazandaran University of Medical Sciences

shervin.amirkhanloo@gmail.com+98 11 3332 2850

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026